162
Participants
Start Date
November 13, 2023
Primary Completion Date
May 30, 2026
Study Completion Date
June 30, 2026
Hemay005
Hemay005 tables 60mg bid p.o;
Hemay005
Hemay005 tables 45mg bid p.o;
Placebo
placebo to Hemay005 tables bid p.o
RECRUITING
Beijing Friendship hospital capital medical hospital, Beijing
RECRUITING
Peking university first hospital, Beijing
RECRUITING
Peking University People's Hospital, Beijing
RECRUITING
Peking university third hospital, Beijing
RECRUITING
Xuanwu hospital capital medical university, Beijing
RECRUITING
The first affiliated hospital of Xiamen University, Xiamen
RECRUITING
Guangdong second provincial central hospital, Guangzhou
RECRUITING
Sun Yat-Sen memorial hospital, Guangzhou
RECRUITING
The third affiliated hospital sun yat-sen university, Guangzhou
RECRUITING
The university of Hong Kong-Shenzhen Hospital, Shenzhen
RECRUITING
Affiliated hospital of Guilin Medical university, Guilin
NOT_YET_RECRUITING
The second hospital of Hebei medical university, Shijiazhuang
RECRUITING
Xinxiang Central hospital, Xinxiang
RECRUITING
The first affiliated hospital of Nanchang university, Nanchang
RECRUITING
The first affiliated hospital of Soochow university, Suzhou
RECRUITING
The affiliated hospital of Xuzhou medical university, Xuzhou
RECRUITING
Jilin Province People's hospital, Changchun
NOT_YET_RECRUITING
Linyi People's Hospital, Linyi
RECRUITING
Tongji hospital of Tongji university, Shanghai
NOT_YET_RECRUITING
Second hospital of shanxi medical university, Taiyuan
RECRUITING
The first affiliated hospital, Zhejiang University school of medicine, Hangzhou
RECRUITING
The first affiliated hospital of Wenzhou Medical university, Wenzhou
Lead Sponsor
Ganzhou Hemay Pharmaceutical Co., Ltd
INDUSTRY